Form 8-K - Current report:
SEC Accession No. 0001104659-18-028525
Filing Date
2018-04-30
Accepted
2018-04-30 16:11:21
Documents
6
Period of Report
2018-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-12317_18k.htm 8-K 26812
2 EX-99.1 a18-12317_1ex99d1.htm EX-99.1 2239482
3 GRAPHIC g123171mm25i001.jpg GRAPHIC 2111
4 GRAPHIC g123171mm25i002.jpg GRAPHIC 8394
5 GRAPHIC g123171bai001.gif GRAPHIC 73
6 GRAPHIC g123171bai002.gif GRAPHIC 73
  Complete submission text file 0001104659-18-028525.txt   2282643
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 18789802
SIC: 2834 Pharmaceutical Preparations